Ontology list
Cellular componentorganelle - GO:0043226; intracellular part - GO:0044424; membrane-bounded organelle - GO:0043227; cellular_component - GO:0005575; nucleoplasm - GO:0005654; intracellular organelle - GO:0043229; nucleus - GO:0005634; intracellular membrane-bounded organelle - GO:0043231; cell part - GO:0044464;
Molecular functionprotein domain specific binding - GO:0019904; identical protein binding - GO:0042802; nucleic acid binding transcription factor activity - GO:0001071; E-box binding - GO:0070888; dna binding - GO:0003677; transcription regulatory region dna binding - GO:0044212; molecular_function - GO:0003674; sequence-specific dna binding transcription factor activity - GO:0003700; regulatory region dna binding - GO:0000975; protein heterodimerization activity - GO:0046982; nucleic acid binding - GO:0003676; bhlh transcription factor binding - GO:0043425; binding - GO:0005488; bHLH transcription factor binding - GO:0043425; regulatory region nucleic acid binding - GO:0001067; transcription factor binding - GO:0008134; protein dimerization activity - GO:0046983; sequence-specific dna binding rna polymerase ii transcription factor activity - GO:0000981; organic cyclic compound binding - GO:0097159; RNA polymerase II transcription factor activity; sequence-specific DNA binding - GO:0000981; protein binding - GO:0005515; protein homodimerization activity - GO:0042803; e-box binding - GO:0070888; heterocyclic compound binding - GO:1901363;
Biological processregulation of transport - GO:0051049; regulation of cellular amino acid metabolic process - GO:0006521; positive regulation of cellular component organization - GO:0051130; regulation of nucleobase-containing compound metabolic process - GO:0019219; neural tube closure - GO:0001843; positive regulation of DNA-templated transcription; initiation - GO:2000144; response to hypoxia - GO:0001666; regulation of transcription; dna-templated - GO:0006355; positive regulation of transcription from rna polymerase ii promoter - GO:0045944; positive regulation of cell morphogenesis involved in differentiation - GO:0010770; positive regulation of protein transport - GO:0051222; regulation of cellular response to stress - GO:0080135; regulation of rna biosynthetic process - GO:2001141; organic substance metabolic process - GO:0071704; positive regulation of fatty acid metabolic process - GO:0045923; regulation of establishment of protein localization - GO:0070201; regulation of phosphorylation - GO:0042325; embryonic cranial skeleton morphogenesis - GO:0048701; negative regulation of dna repair - GO:0045738; negative regulation of biosynthetic process - GO:0009890; regulation of monocyte chemotactic protein-1 production - GO:0071637; embryonic camera-type eye formation - GO:0060900; single-organism developmental process - GO:0044767; response to decreased oxygen levels - GO:0036293; positive regulation of tumor necrosis factor production - GO:0032760; regulation of angiogenesis - GO:0045765; positive regulation of rna metabolic process - GO:0051254; cellular aromatic compound metabolic process - GO:0006725; organic substance biosynthetic process - GO:1901576; osteoblast differentiation - GO:0001649; transcription; dna-templated - GO:0006351; regulation of sequence-specific dna binding transcription factor activity - GO:0051090; regulation of programmed cell death - GO:0043067; regulation of dna metabolic process - GO:0051052; regulation of transmembrane transport - GO:0034762; negative regulation of cell differentiation - GO:0045596; neuron migration - GO:0001764; negative regulation of cell communication - GO:0010648; cellular process - GO:0009987; atrioventricular valve morphogenesis - GO:0003181; negative regulation of cellular amine metabolic process - GO:0033239; negative regulation of oxidative phosphorylation uncoupler activity - GO:2000276; negative regulation of nitrogen compound metabolic process - GO:0051172; response to chemical - GO:0042221; positive regulation of molecular function - GO:0044093; positive regulation of cell proliferation - GO:0008284; regulation of dna repair - GO:0006282; response to stimulus - GO:0050896; regulation of anatomical structure morphogenesis - GO:0022603; regulation of locomotion - GO:0040012; cellular macromolecule metabolic process - GO:0044260; regulation of cellular component organization - GO:0051128; regulation of cellular protein metabolic process - GO:0032268; negative regulation of transcription; DNA-templated - GO:0045892; regulation of biomineral tissue development - GO:0070167; regulation of cellular localization - GO:0060341; developmental process - GO:0032502; regulation of phosphate metabolic process - GO:0019220; negative regulation of tumor necrosis factor superfamily cytokine production - GO:1903556; anatomical structure morphogenesis - GO:0009653; positive regulation of epithelial to mesenchymal transition - GO:0010718; regulation of muscle organ development - GO:0048634; negative regulation of molecular function - GO:0044092; negative regulation of gene expression - GO:0010629; regulation of response to dna damage stimulus - GO:2001020; negative regulation of signal transduction - GO:0009968; positive regulation of transport - GO:0051050; regulation of multicellular organismal process - GO:0051239; rhythmic process - GO:0048511; regulation of histone phosphorylation - GO:0033127; negative regulation of chromatin modification - GO:1903309; regulation of double-strand break repair - GO:2000779; positive regulation of dna-templated transcription; initiation - GO:2000144; regulation of cell development - GO:0060284; organic cyclic compound metabolic process - GO:1901360; positive regulation of cellular catabolic process - GO:0031331; negative regulation of nucleic acid-templated transcription - GO:1903507; regulation of histone modification - GO:0031056; positive regulation of tumor necrosis factor superfamily cytokine production - GO:1903557; cellular response to stimulus - GO:0051716; endocardial cushion morphogenesis - GO:0003203; heterocycle metabolic process - GO:0046483; negative regulation of tumor necrosis factor production - GO:0032720; regulation of secretion by cell - GO:1903530; positive regulation of angiogenesis - GO:0045766; regulation of biological process - GO:0050789; negative regulation of skeletal muscle tissue development - GO:0048642; cell migration - GO:0016477; organic cyclic compound biosynthetic process - GO:1901362; regulation of gene expression - GO:0010468; negative regulation of histone acetylation - GO:0035067; heart valve morphogenesis - GO:0003179; cell differentiation - GO:0030154; response to oxygen levels - GO:0070482; positive regulation of transcription regulatory region dna binding - GO:2000679; cytokine-mediated signaling pathway - GO:0019221; regulation of striated muscle tissue development - GO:0016202; regulation of transcription from rna polymerase ii promoter - GO:0006357; regulation of cell differentiation - GO:0045595; negative regulation of transport - GO:0051051; regulation of cell death - GO:0010941; organ development - GO:0048513; embryo development ending in birth or egg hatching - GO:0009792; nucleic acid-templated transcription - GO:0097659; negative regulation of peroxisome proliferator activated receptor signaling pathway - GO:0035359; cellular response to hypoxia - GO:0071456; embryonic organ morphogenesis - GO:0048562; nucleic acid metabolic process - GO:0090304; metabolic process - GO:0008152; aromatic compound biosynthetic process - GO:0019438; organ morphogenesis - GO:0009887; negative regulation of developmental process - GO:0051093; negative regulation of sequence-specific DNA binding transcription factor activity - GO:0043433; negative regulation of cellular biosynthetic process - GO:0031327; regulation of multicellular organismal development - GO:2000026; positive regulation of interleukin-6 secretion - GO:2000778; negative regulation of transcription from rna polymerase ii promoter - GO:0000122; regulation of secretion - GO:0051046; regulation of fatty acid beta-oxidation - GO:0031998; embryonic morphogenesis - GO:0048598; positive regulation of gene expression - GO:0010628; negative regulation of histone phosphorylation - GO:0033128; negative regulation of transcription; dna-templated - GO:0045892; regulation of macromolecule metabolic process - GO:0060255; muscle structure development - GO:0061061; regulation of response to stimulus - GO:0048583; positive regulation of cellular process - GO:0048522; regulation of cell aging - GO:0090342; regulation of cellular process - GO:0050794; embryonic skeletal system morphogenesis - GO:0048704; ameboidal-type cell migration - GO:0001667; positive regulation of fatty acid oxidation - GO:0046321; muscle organ development - GO:0007517; regulation of organ morphogenesis - GO:2000027; positive regulation of transcription; dna-templated - GO:0045893; cellular metabolic process - GO:0044237; regulation of macromolecule biosynthetic process - GO:0010556; negative regulation of protein modification process - GO:0031400; regulation of protein transport - GO:0051223; negative regulation of response to dna damage stimulus - GO:2001021; regulation of protein phosphorylation - GO:0001932; in utero embryonic development - GO:0001701; negative regulation of protein acetylation - GO:1901984; cellular response to stress - GO:0033554; negative regulation of cellular senescence - GO:2000773; regulation of cell communication - GO:0010646; negative regulation of phosphatidylinositol 3-kinase signaling - GO:0014067; regulation of protein localization - GO:0032880; positive regulation of cell motility - GO:2000147; positive regulation of biological process - GO:0048518; tube closure - GO:0060606; movement of cell or subcellular component - GO:0006928; regulation of oxidative phosphorylation uncoupler activity - GO:2000275; nitrogen compound metabolic process - GO:0006807; rna biosynthetic process - GO:0032774; regulation of organelle organization - GO:0033043; positive regulation of stem cell differentiation - GO:2000738; negative regulation of striated muscle tissue development - GO:0045843; primary metabolic process - GO:0044238; regulation of nucleic acid-templated transcription - GO:1903506; cell motility - GO:0048870; negative regulation of chromosome organization - GO:2001251; skeletal system morphogenesis - GO:0048705; regulation of skeletal muscle tissue development - GO:0048641; chordate embryonic development - GO:0043009; regulation of osteoblast differentiation - GO:0045667; positive regulation of lipid metabolic process - GO:0045834; positive regulation of cell differentiation - GO:0045597; regulation of signaling - GO:0023051; locomotion - GO:0040011; negative regulation of cellular component organization - GO:0051129; embryonic hindlimb morphogenesis - GO:0035116; regulation of signal transduction by p53 class mediator - GO:1901796; negative regulation of response to stimulus - GO:0048585; regulation of rna metabolic process - GO:0051252; positive regulation of monocyte chemotactic protein-1 production - GO:0071639; negative regulation of cell aging - GO:0090344; outer ear morphogenesis - GO:0042473; negative regulation of transmembrane transport - GO:0034763; cellular response to organic substance - GO:0071310; regulation of transcription regulatory region dna binding - GO:2000677; regulation of protein acetylation - GO:1901983; positive regulation of multicellular organismal process - GO:0051240; positive regulation of transcription from RNA polymerase II promoter - GO:0045944; regulation of ossification - GO:0030278; response to abiotic stimulus - GO:0009628; regulation of protein complex assembly - GO:0043254; single-multicellular organism process - GO:0044707; regulation of cellular component movement - GO:0051270; cellular nitrogen compound biosynthetic process - GO:0044271; regulation of cell morphogenesis involved in differentiation - GO:0010769; negative regulation of multicellular organismal process - GO:0051241; negative regulation of DNA damage response; signal transduction by p53 class mediator - GO:0043518; positive regulation of metabolic process - GO:0009893; positive regulation of cytokine production - GO:0001819; positive regulation of cellular component biogenesis - GO:0044089; negative regulation of signaling - GO:0023057; negative regulation of organelle organization - GO:0010639; regulation of cellular metabolic process - GO:0031323; regulation of phosphatidylinositol 3-kinase signaling - GO:0014066; negative regulation of transcription from RNA polymerase II promoter - GO:0000122; regulation of chromosome organization - GO:0033044; positive regulation of interleukin-6 production - GO:0032755; negative regulation of dna damage response; signal transduction by p53 class mediator - GO:0043518; regulation of biosynthetic process - GO:0009889; regulation of localization - GO:0032879; biosynthetic process - GO:0009058; positive regulation of binding - GO:0051099; positive regulation of nucleic acid-templated transcription - GO:1903508; negative regulation of metabolic process - GO:0009892; anatomical structure formation involved in morphogenesis - GO:0048646; regulation of interleukin-6 production - GO:0032675; negative regulation of ossification - GO:0030279; appendage morphogenesis - GO:0035107; regulation of binding - GO:0051098; negative regulation of muscle tissue development - GO:1901862; negative regulation of biological process - GO:0048519; negative regulation of cytokine production - GO:0001818; negative regulation of protein metabolic process - GO:0051248; response to organic substance - GO:0010033; positive regulation of nitrogen compound metabolic process - GO:0051173; positive regulation of macromolecule biosynthetic process - GO:0010557; cellular response to chemical stimulus - GO:0070887; negative regulation of transporter activity - GO:0032410; cellular nitrogen compound metabolic process - GO:0034641; positive regulation of cellular metabolic process - GO:0031325; biological_process - GO:0008150; regulation of transmembrane transporter activity - GO:0022898; cellular response to growth factor stimulus - GO:0071363; regulation of proton transport - GO:0010155; embryonic forelimb morphogenesis - GO:0035115; positive regulation of cellular biosynthetic process - GO:0031328; regulation of cell morphogenesis - GO:0022604; regulation of signal transduction - GO:0009966; negative regulation of cell death - GO:0060548; regulation of epithelial to mesenchymal transition - GO:0010717; negative regulation of signal transduction by p53 class mediator - GO:1901797; single-organism cellular process - GO:0044763; negative regulation of cellular metabolic process - GO:0031324; cellular response to oxygen levels - GO:0071453; positive regulation of epithelial cell proliferation - GO:0050679; nucleobase-containing compound biosynthetic process - GO:0034654; cellular biosynthetic process - GO:0044249; positive regulation of cytokine secretion - GO:0050715; positive regulation of cell development - GO:0010720; embryonic limb morphogenesis - GO:0030326; negative regulation of rna biosynthetic process - GO:1902679; biological regulation - GO:0065007; regulation of lipid catabolic process - GO:0050994; negative regulation of double-strand break repair - GO:2000780; negative regulation of macromolecule metabolic process - GO:0010605; regulation of cellular macromolecule biosynthetic process - GO:2000112; regulation of dna damage response; signal transduction by p53 class mediator - GO:0043516; regulation of cellular ketone metabolic process - GO:0010565; regulation of intracellular signal transduction - GO:1902531; regulation of fatty acid metabolic process - GO:0019217; regulation of cytokine secretion - GO:0050707; negative regulation of cellular protein metabolic process - GO:0032269; negative regulation of cellular amino acid metabolic process - GO:0045763; embryonic appendage morphogenesis - GO:0035113; palate development - GO:0060021; positive regulation of nucleobase-containing compound metabolic process - GO:0045935; regulation of transporter activity - GO:0032409; cell proliferation involved in heart valve development - GO:2000793; negative regulation of osteoblast differentiation - GO:0045668; response to stress - GO:0006950; aortic valve morphogenesis - GO:0003180; rna metabolic process - GO:0016070; mesenchyme morphogenesis - GO:0072132; response to growth factor - GO:0070848; ossification - GO:0001503; embryonic digit morphogenesis - GO:0042733; negative regulation of peptidyl-lysine acetylation - GO:2000757; cellular developmental process - GO:0048869; regulation of epithelial cell proliferation - GO:0050678; regulation of chemokine production - GO:0032642; regulation of apoptotic process - GO:0042981; negative regulation of muscle organ development - GO:0048635; regulation of lipid metabolic process - GO:0019216; eyelid development in camera-type eye - GO:0061029; limb morphogenesis - GO:0035108; regulation of molecular function - GO:0065009; cell migration involved in heart development - GO:0060973; regulation of bone mineralization - GO:0030500; nucleobase-containing compound metabolic process - GO:0006139; heterocycle biosynthetic process - GO:0018130; regulation of primary metabolic process - GO:0080090; negative regulation of programmed cell death - GO:0043069; odontogenesis - GO:0042476; regulation of fatty acid oxidation - GO:0046320; positive regulation of biosynthetic process - GO:0009891; regulation of cytokine production - GO:0001817; regulation of dna-templated transcription; initiation - GO:2000142; craniofacial suture morphogenesis - GO:0097094; regulation of nitrogen compound metabolic process - GO:0051171; regulation of protein secretion - GO:0050708; positive regulation of locomotion - GO:0040017; negative regulation of dna metabolic process - GO:0051053; negative regulation of sequence-specific dna binding transcription factor activity - GO:0043433; regulation of response to stress - GO:0080134; embryo development - GO:0009790; regulation of cellular component biogenesis - GO:0044087; positive regulation of transcription regulatory region DNA binding - GO:2000679; cell proliferation - GO:0008283; regulation of cellular biosynthetic process - GO:0031326; positive regulation of fatty acid beta-oxidation - GO:0032000; regulation of protein modification process - GO:0031399; regulation of endocardial cushion to mesenchymal transition involved in heart valve formation - GO:2000800; regulation of chromatin modification - GO:1903308; regulation of heart morphogenesis - GO:2000826; regulation of metabolic process - GO:0019222; negative regulation of cellular process - GO:0048523; regulation of tumor necrosis factor production - GO:0032680; cellular response to decreased oxygen levels - GO:0036294; positive regulation of catabolic process - GO:0009896; neural crest cell migration - GO:0001755; tube formation - GO:0035148; regulation of peroxisome proliferator activated receptor signaling pathway - GO:0035358; regulation of vasculature development - GO:1901342; multicellular organismal process - GO:0032501; cellular macromolecule biosynthetic process - GO:0034645; regulation of phosphorus metabolic process - GO:0051174; macromolecule biosynthetic process - GO:0009059; tissue morphogenesis - GO:0048729; positive regulation of secretion by cell - GO:1903532; anatomical structure development - GO:0048856; transcription from rna polymerase ii promoter - GO:0006366; positive regulation of cellular component movement - GO:0051272; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation - GO:2000802; positive regulation of secretion - GO:0051047; positive regulation of rna biosynthetic process - GO:1902680; negative regulation of rna metabolic process - GO:0051253; regulation of chromatin organization - GO:1902275; positive regulation of chemokine production - GO:0032722; regulation of cell proliferation - GO:0042127; negative regulation of histone modification - GO:0031057; negative regulation of phosphorus metabolic process - GO:0010563; single-organism process - GO:0044699; negative regulation of nucleobase-containing compound metabolic process - GO:0045934; hindlimb morphogenesis - GO:0035137; regulation of dna binding - GO:0051101; positive regulation of protein secretion - GO:0050714; regulation of cell motility - GO:2000145; positive regulation of protein complex assembly - GO:0031334; negative regulation of intracellular signal transduction - GO:1902532; mitral valve morphogenesis - GO:0003183; positive regulation of dna binding - GO:0043388; negative regulation of phosphorylation - GO:0042326; negative regulation of cellular macromolecule biosynthetic process - GO:2000113; negative regulation of phosphate metabolic process - GO:0045936; regulation of stem cell differentiation - GO:2000736; negative regulation of macromolecule biosynthetic process - GO:0010558; negative regulation of ion transport - GO:0043271; regulation of developmental process - GO:0050793; macromolecule metabolic process - GO:0043170; regulation of catabolic process - GO:0009894; positive regulation of macromolecule metabolic process - GO:0010604; regulation of ion transport - GO:0043269; regulation of histone acetylation - GO:0035065; negative regulation of apoptotic process - GO:0043066; regulation of cellular amine metabolic process - GO:0033238; cranial suture morphogenesis - GO:0060363; positive regulation of developmental process - GO:0051094; cardiac neural crest cell migration involved in outflow tract morphogenesis - GO:0003253; regulation of muscle tissue development - GO:1901861; regulation of protein metabolic process - GO:0051246; negative regulation of protein phosphorylation - GO:0001933; forelimb morphogenesis - GO:0035136; positive regulation of lipid catabolic process - GO:0050996; regulation of cellular senescence - GO:2000772; regulation of tumor necrosis factor superfamily cytokine production - GO:1903555; regulation of cellular catabolic process - GO:0031329; regulation of peptidyl-lysine acetylation - GO:2000756;